Oncimmune Holdings plc (ONC) Ordinary 1p
- Add to watchlist
- Create an alert
- This stock can be held in a
25.40p
25.40p
44.00p
£18.83 million
24.10p
22.81p
13.00p
n/a
0.50p (2.12%) Previous:
0.50p
37,641
n/a
10,000
Performance
Not available for this stock.
Fundamental data
Year ending: | 31/08/2023 | 31/08/2022 |
---|---|---|
Revenue (£m) | 1.15 | 2.32 |
Profit before tax (£m) | (5.93) | (6.58) |
Adjusted EPS (p): | (8.47) | (7.91) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Oncimmune revenue falls as it implements new strategy
29 February 2024 13:04
-
Oncimmune sells 'non-core' lung and antibody assets in £13m deal
22 May 2023 11:14
-
Oncimmune enters collaboration with Siemens Healthineers
17 February 2023 15:53
-
Appointment of Nominated Adviser and Joint Broker
26 April 2024 07:00
-
Holding(s) in Company
25 April 2024 10:44
-
Result of General Meeting
2 April 2024 11:34
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.